Delivery Order SPE2DE21D7010-SPE2D626F43FW
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,287.94 on January 27, 2026, by the Defense Logistics Agency Medical Supply Chain for the supply of MODULUS spinal surgical products. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 28, 2026, with performance conducted at Nuvasive's San Diego, California facility. The award was made...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and services, has been awarded a delivery order valued at $22,408.89 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The contract, which carries no set-aside designation, is for the delivery of MODULUS spinal medical products and is structured as a fixed-price agreement with economic price adjustment provisions. Performance is scheduled to conclude by October...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, was awarded a $11,287.94 fixed-price delivery order (Contract 4569593362) by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The delivery order, which includes economic price adjustment provisions, is designated for the MODULUS product line and has an ultimate completion date of September 23, 2025. The contract was awarded without set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order contract valued at $7,358.52 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, with a completion date of October 24, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment mechanisms and covers the supply of the MODULUS spinal surgical product to support federal healthcare operations. This award...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,969.84 delivery order by the Defense Logistics Agency Medical Supply Chain on December 11, 2025, for MODULUS spinal surgical products. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, indicating open market competition. Performance will be completed at Nuvasive's San Diego facility by December...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $5,293.64 on January 22, 2026, for MODULUS spinal surgical products and services. This fixed-price contract with economic price adjustment is scheduled for completion by February 17, 2026, and will be performed at Nuvasive's San Diego facility. The award was issued under a competitive, open-market procurement with no set-aside designation by the...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc. was awarded a $21,488.67 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency, on April 29, 2025. The delivery order, which is not set-aside designated, requires completion by May 19, 2025, and will be performed in San Diego, California. As a leading medical device manufacturer specializing in spinal surgery products, Nuvasive supplies advanced spinal implants, fusion devices,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $20,821.36 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on October 23, 2025. The delivery order, designated as Contract No. 4569849710 for MODULUS spinal surgical products, carries an ultimate completion date of November 18, 2025, and will be performed at Nuvasive's San Diego, California facility. This award...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $4,346 fixed-price delivery order with economic price adjustment (FPEA) by the Defense Logistics Agency (DLA) Medical Supply Chain on November 26, 2025, with a completion date of January 5, 2026. This delivery order, issued without set-aside designation, represents a competitive open-market procurement for specialized spinal surgical products and services to support...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F43FWDelivery Order
Nuvasive, Inc. was awarded a delivery order valued at $22,168.78 by the Defense Logistics Agency (DLA) Medical Supply Chain on February 4, 2026, with an ultimate completion date of February 25, 2026. The award is structured as a fixed-price delivery order with economic price adjustment pricing and includes the MODULUS spinal surgical product. This delivery order was issued without a set-aside designation, demonstrating Nuvasive's competitive standing in open market procurements. The place of performance is San Diego, California, where Nuvasive maintains its primary manufacturing and fulfillment operations. This delivery order is issued against Nuvasive's broader contracting relationship with federal healthcare agencies, particularly the Defense Logistics Agency and Defense Health Agency, which procure specialized spinal implants and surgical devices for Department of Defense and Department of Veterans Affairs medical facilities. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts Division, has established itself as a critical supplier of advanced spinal fusion devices, interbody implants, bone graft materials, and specialized surgical instruments to military and veteran healthcare systems. The company operates under an $8 million Blanket Purchase Agreement with the Defense Health Agency (Indefinite Delivery/Indefinite Quantity vehicle) effective through March 2027, which facilitates streamlined procurement of its comprehensive spinal technology portfolio across federal healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.2k | 2/3/26 |